Warning letter
Duramed Pharmaceuticals Inc.: warning letter of Dec 6, 2000
FDA warning letter UCM069117 · New Jersey District Office
Key facts
| Reference number | UCM069117 |
|---|---|
| Company | Duramed Pharmaceuticals Inc. |
| Subject | Good Manufacturing Processing Packing Holding/Finished Pharmaceuticals/Adulterated |
| Issue date | Dec 6, 2000 |
| Posted date | Dec 6, 2000 |
| Issuing office | New Jersey District Office |
| Product type | Drugs |
| Country | 3 |
| Inspection city | Somerset |
| Inspection ZIP | 08873-1145 |
| Inspection start date | Sep 26, 2000 |
| Letter on fda.gov | web.archive.org |
At a glance
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: